Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Twitter Email Maria Mar Hernandez Guillamon Twitter Email Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Research lines Cerebral Amyloidosis The primary objective of this research line is to deepen the understanding of the pathophysiology of cerebral amyloid angiopathy (CAA), a neurovascular disease linked to Alzheimer’s and other cognitive disorders. More specifically, the focus is on identifying diagnostic and clinical progression biomarkers in patients with intracerebral hemorrhage and CAA, as well as investigating new therapeutic strategies in models of cerebral beta-amyloidosis, with the goal of improving the treatments available for these conditions. IP: Maria Mar Hernandez Guillamon Projects PReDICT: Pediatric Stroke Rare Disorders: Integrative Diagnosis and Treatment using Multi-Omics and Deep Learning IP: Belen Perez Dueñas Collaborators: Marta Codina Solà, Maria Mar Hernandez Guillamon, Anna Rosell Novel, David Gómez Andrés Funding agency: Instituto de Salud Carlos III Funding: 185165.07 Reference: PMPER24/00021 Duration: 01/01/2025 - 31/12/2026 Papel de la proteína MFGE8 como potencial biomarcador y diana terapéutica en la angiopatía amiloide cerebral IP: Maria Mar Hernandez Guillamon Collaborators: Berta Paez Montserrat, Kerrie Adrián Campbell, Jessica Camacho Soriano, Anas Chaachou Charradi, Olalla Pancorbo Rosal Funding agency: Instituto de Salud Carlos III Funding: 208750 Reference: PI23/00082 Duration: 01/01/2024 - 31/12/2026 Tejiendo Ciencia IP: Ariadna Laguna Tuset Collaborators: Anna Santamaria Margalef, Maria Mar Hernandez Guillamon, Sara Mas Assens Funding agency: Fundación Española Ciencia y Tecnología (FECYT) Funding: 15000 Reference: FCT-2023-19804 Duration: 01/12/2024 - 30/11/2025 Implication of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy IP: Maria Mar Hernandez Guillamon Collaborators: Berta Paez Montserrat, Laia Perez Lasarte Funding agency: FUNDACIÓN JOSEP PALAU FRANCÀS Funding: 68873.32 Reference: VHIRFRANCAS/PREDOC/2022 Duration: 01/02/2023 - 31/01/2026 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page »
